Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
25 June 2024
21 June 2024
| m 23:48 | Bevacizumab-adcd (Vegzelga) diffhist +10 Jwarner talk contribs →Also known as | ||||
| m 23:47 | Bevacizumab-maly (Alymsys) diffhist +9 Jwarner talk contribs →Also known as | ||||
| N 23:42 | Bevacizumab-tnjn (Avzivi) diffhist +4,211 Jwarner talk contribs Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Bevacizumab (Avastin) page, except for the details of FDA indication and the refe..." | ||||
18 June 2024
|
|
m 10:54 | Pembrolizumab (Keytruda) 2 changes history +220 [Jwarner (2×)] | |||
| m |
|
10:54 (cur | prev) -2 Jwarner talk contribs | |||
| m |
|
10:53 (cur | prev) +222 Jwarner talk contribs →Endometrial cancer | |||